{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:35:10Z","timestamp":1777581310924,"version":"3.51.4"},"reference-count":39,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>Integrated Care (IC) is a perfect fit for people with diabetes. Fundus examination (FE) is a disease marker for diabetologists and identifies potentially blinding complications (Diabetic Retinopathy, DR). In our Diabetes Clinic (DC) in Pescara, Italy, FE is possibly provided with telemedicine in same day as other exams, avoiding it to be a standalone clinical one; images taken with a retinal digital camera are graded by a remote ophthalmologist within a shared Electronic Health Record (EHR), immediately readable by other stakeholders; a dedicated care path to the Eye Clinic, University of Chieti-Pescara is provided for urgent cases. Personnel\u2019s worktime shortening allows gaining time for ophthalmologists\u2019 eye examinations in outpatient settings and other stakeholders\u2019 work in the DC. The need for a DR digital screening system is growing worldwide: our experience confirms the ease of implementation, and the advantage of sharing clinical data with all stakeholders when working within an EHR, aiming to optimize an IC effective system.<\/jats:p>","DOI":"10.1177\/11206721211039346","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T01:47:25Z","timestamp":1629769645000},"page":"2382-2387","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Welcoming teleretinography into diabetes integrated care"],"prefix":"10.1177","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5137-0699","authenticated-orcid":false,"given":"Roberto","family":"Perilli","sequence":"first","affiliation":[{"name":"Territorial Ophthalmology Unit, Local Health Authority, Pescara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio P","family":"Mariotti","sequence":"additional","affiliation":[{"name":"Department of Chronic Diseases and Health Promotion, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Mastropasqua","sequence":"additional","affiliation":[{"name":"Eye Clinic and National Centre for Excellence in Ophthalmology, University of Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3238-9682","authenticated-orcid":false,"given":"Francesco M","family":"Bandello","sequence":"additional","affiliation":[{"name":"Eye Clinic, San Raffaele Hospital, Vita-Salute University, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Grigioni","sequence":"additional","affiliation":[{"name":"National Centre for Innovative Technologies in Public Health, Istituto Superiore di Sanit\u00e0, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Tarricone","sequence":"additional","affiliation":[{"name":"Department of Social and Political Sciences, Bocconi University, Milan, Italy"},{"name":"Centre for Research in Health and Social Care Management (CERGAS), Government, Health and Non Profit Division, SDA Bocconi, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Petracca","sequence":"additional","affiliation":[{"name":"Centre for Research in Health and Social Care Management (CERGAS), Government, Health and Non Profit Division, SDA Bocconi, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostino","family":"Consoli","sequence":"additional","affiliation":[{"name":"Chair of Endocrinology and Metabolic Diseases, University of Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"key":"bibr1-11206721211039346","unstructured":"International Diabetes Federation. Diabetes facts and figures, www.idf.org\/aboutdiabetes\/what-is-diabetes\/facts-figures.html (2020, accessed 12 January 2021)."},{"key":"bibr2-11206721211039346","unstructured":"Diabetes UK. Improving the delivery of adult diabetes care through integration, www.diabetes.org.uk\/professionals\/position-statements-reports\/integrated-diabetes-care (2014, accessed 12 January 2021)."},{"key":"bibr3-11206721211039346","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2641"},{"key":"bibr4-11206721211039346","unstructured":"World Health Organization. Use of Glycated haemoglobin (HbA1c) in the diagnosis of Diabetes Mellitus. Abbreviated report of a WHO consultation, https:\/\/apps.who.int\/iris\/handle\/10665\/70523 (2011, accessed 5 January 2021)."},{"key":"bibr5-11206721211039346","unstructured":"American Academy of Ophthalmology. Diabetic retinopathy preferred practice pattern 2019, www.aao.org\/preferred-practice-pattern\/diabetic-retinopathy-ppp (2019, accessed 8 January 2021)."},{"key":"bibr6-11206721211039346","unstructured":"Public Health England. Breaking down barriers to diabetes eye screening attendance, https\/\/:phescreening.blog.gov.uk\/2018\/11\/14\/breaking-down-barriers-to-diabetes-eye-screening-attendance\/ (2018, accessed 10 January 2021)."},{"key":"bibr7-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-13389-8_1"},{"key":"bibr8-11206721211039346","unstructured":"World Health Organization. Blindness and vision impairment, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment (2021, accessed 27 February 2021)."},{"key":"bibr9-11206721211039346","unstructured":"Associazione Medici Diabetologi. Societ\u00e0 Italiana di Diabetologia. Standard italiani per la cura del Diabete Mellito, https:\/\/www.siditalia.it\/clinica\/standard-di-cura-amd-sid (2016, accessed 20 January 2021)."},{"key":"bibr10-11206721211039346","unstructured":"NHS Screening Programmes \u2013 Diabetic Eye. Diabetic eye screening feature based grading forms. Guidance on standard feature based grading forms to be used in the NHS Diabetic Eye Screening Programme. Version 1.4, https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/402295\/Feature_Based_Grading_Forms_V1_4_1Nov12_SSG.pdf (2012, accessed 22 January 2021)."},{"key":"bibr11-11206721211039346","unstructured":"NHS Public Health England \u2013 NHS Diabetic Eye Screening Programme. Grading definitions for referable disease, https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/582710\/Grading_definitions_for_referrable_disease_2017_new_110117.pdf (2017, accessed 22 January 2021)."},{"key":"bibr12-11206721211039346","volume-title":"Tempi Medi di Attivit\u00e0, Modalit\u00e0 di Esecuzione, Nomenclatore delle Prestazioni Specialistiche Ambulatoriali Territoriali","author":"Societ\u00e0 Italiana di Medicina Specialistica \u2013 Sindacato Unico Medicina Ambulatoriale Italiana","year":"2006"},{"key":"bibr13-11206721211039346","unstructured":"Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, cdc.gov\/visionhealth\/pdf\/factsheet.pdf (2011, accessed 25 January 2021)."},{"key":"bibr14-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180949"},{"key":"bibr15-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181884f2d"},{"key":"bibr16-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30315-6"},{"key":"bibr17-11206721211039346","unstructured":"Perilli R, Grigioni M, Porta M, et al. Contributo dell\u2019innovazione tecnologica alla sicurezza del paziente diabetico da sottoporre ad esame del fondo oculare in tempi di COVID-19. Versione del 31 maggio 2020. Roma: Istituto Superiore di Sanit\u00e0, 2020. Rapporto ISS COVID-19 n. 50\/2020Rev) (abstract in English). www.iss.it\/rapporti-covid-19\/-\/asset_publisher\/btw1J82wtYzH\/content\/rapporti-iss-covid-19-n.50-2020-contributo-dell-innovazione-tecnologica-alla-sicurezza-del-paziente-diabetico-da-sottoporre-ad-esame-del-fondo-oculare-in-tempi-di-covid-19.versione-del-31-maggio-2020"},{"key":"bibr18-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-020-04879-2"},{"key":"bibr19-11206721211039346","unstructured":"Wilson JMG, Jungner G. Principles and practice of screening for disease, Geneva WHO, Public Health Papers, n. 34, 1968."},{"key":"bibr20-11206721211039346","unstructured":"Centers for Disease Control. Vision health initiative. Economic studies. Cost-effectiveness model for diabetic retinopathy, https:\/\/www.cdc.gov\/visionhealth\/projects\/economic_studies.htm (2020, accessed 12 January 2021)."},{"key":"bibr21-11206721211039346","unstructured":"Deloitte Access Economics. The economic impact of diabetic macular edema in Australia. Canberra: Bayer Australia Ltd, 2015. https:\/\/www2.deloitte.com\/au\/en\/pages\/economics\/articles\/economic-impact-diabetic-eye-disease.html (2020, accessed 12 January 2021)."},{"key":"bibr22-11206721211039346","unstructured":"European Commission \u2013 Action Group B3. European innovation partnership on active and healthy ageing. Replicating and tutoring integrated care for chronic diseases, including remote monitoring at regional level. A compilation of good practices. 2nd ed. 2013. www.ec.europa.eu\/eip\/ageing\/actiongroup\/index\/b3\/key-documents_en.html (accessed 27th January 2021)."},{"key":"bibr23-11206721211039346","unstructured":"World Health Organization. World report on vision 2019, www.who.int\/publications-detail\/world-report-on-vision (2020, accessed 12 January 2021)."},{"key":"bibr24-11206721211039346","unstructured":"gov.uk. Diabetic eye screening: programme overview \u2013 an overview of the NHS diabetic eye screening (DES) programme, its services and contact information, https:\/\/www.gov.uk\/guidance\/diabetic-eye-screening-programme-overview (2020, accessed 12 January 2021)."},{"key":"bibr25-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-016-0206-4"},{"key":"bibr26-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040196"},{"key":"bibr27-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022594"},{"key":"bibr28-11206721211039346","unstructured":"Ministero della Salute. Livelli Essenziali di Assistenza, DPCM 12 gennaio 2017 allegato 4: Nomenclatore prestazioni di assistenza specialistica ambulatoriale, http:\/\/www.salute.gov.it\/portale\/lea\/dettaglioContenutiLea.jsp?lingua=italiano&id=4773&area=Lea&menu=vuoto (2017, accessed 3 February 2021)."},{"key":"bibr29-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1080\/09286586.2020.1715450"},{"key":"bibr30-11206721211039346","unstructured":"American Academy of Ophthalmology \u2013 EyeWiki. Hypertensive retinopathy, https:\/\/eyewiki.aao.org\/Hypertensive_retinopathy (2021, accessed 10 May 2021)."},{"key":"bibr31-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220506"},{"key":"bibr32-11206721211039346","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0264"},{"key":"bibr33-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.1540"},{"key":"bibr34-11206721211039346","unstructured":"World Health Organization Regional Office for Europe. Diabetic retinopathy screening: a short guide, https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/336660\/9789289055321-eng.pdf (2020, accessed 15 April 2021)."},{"key":"bibr35-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2020.0006"},{"key":"bibr36-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2018.07.004"},{"key":"bibr37-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1189-3"},{"key":"bibr38-11206721211039346","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(20)30060-1"},{"key":"bibr39-11206721211039346","first-page":"e144","volume":"9","author":"GBD 2019 Blindness and Vision Impairment Collaborators and Vision Loss Expert Group of the Global Burden of Disease Study","year":"2021","journal-title":"Lancet"}],"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721211039346","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11206721211039346","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721211039346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:44:53Z","timestamp":1777405493000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11206721211039346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1177\/11206721211039346"],"URL":"https:\/\/doi.org\/10.1177\/11206721211039346","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]}}}